Dan O'Brien

Dan O'Brien is a strategic communications professional with extensive experience in the biopharma and consulting sectors. Currently with US Pharmacopeia since January 2024, O'Brien leads communication efforts on critical issues such as drug shortages and biologic medicines while managing strategies for complex generics and AAV portfolios. Previously, O'Brien held the role of Corporate Communications and External Affairs at MindMed, where skillful brand refinement and impressive growth in media reach were achieved. Experience also includes strategic communications at 150BOND, senior analyst responsibilities at Atlantic Media, co-writing for Reflexive, and an analyst position at J.P. Morgan. Dan O'Brien holds a Bachelor’s Degree in Economics and Business from Trinity College Dublin.